The objectives of this study were to prepare topical gel containing lornoxicam for improved skin penetration of lornoxicam (LNX) for enhancement of its analgesic, anti-inflammation activity and to evaluate the impacts of different penetration enhancers on the in vitro diffusion of lornoxicam.